STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
- PMID: 35928809
- PMCID: PMC9345496
- DOI: 10.3389/fimmu.2022.902652
STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria
Abstract
Background: The pathogenesis of chronic spontaneous urticaria (CSU) has not been clarified entirely. Type IIb autoimmune chronic spontaneous urticaria (CSUaiTIIb) is a distinct subtype of CSU that is often difficult to treat and is connected to low levels of total IgE. Previous findings indicate that an enhanced signal transducer and activator of transcription 3 (STAT3) may be responsible for reduced IgE serum levels.
Objective: Our aim was to investigate a possible underlying gain-of-function mutation or activating polymorphism in STAT3 that could be responsible for the low levels of IgE in patients with CSUaiTIIb.
Methods: We included 10 patients with CSUaiTIIb and low levels of IgE and sequenced selected single nucleotide polymorphisms (SNP) in STAT3 associated with common autoimmune diseases. Exon sequencing was performed for the most relevant exons of STAT3. To test for a gain-of-function of STAT3, we performed a phospho-specific flow cytometry analysis of STAT3 in peripheral blood mononuclear cells before and after stimulation with interleukin-6.
Results: No differences were found in the prevalence of the tested SNPs between our patients and a control population. Moreover, we could not find any mutations or variants on the tested exons of STAT3. The function of STAT3 was also not altered in our patients.
Conclusion: In total, we could not find any evidence for our hypothesis that low IgE in patients with CSUaiTIIb is linked to mutations in STAT3 or altered activity of STAT3. Thus, it remains to be discovered what causes the low serum levels of IgE in patients with CSUaiTIIb.
Keywords: autoimmune disease; autoreactivity; basophil activation test; chronic spontaneous urticaria; gain-of-function mutation; immunoglobulin E; mast cell; signal transducer and activator of transcription 3.
Copyright © 2022 Sauer, Scheffel, Frischbutter, Mahnke, Maurer, Burmeister, Krause and Metz.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Expression of STAT3, IL27p28 and IL12p35 is deregulated and linked to autoimmune markers in chronic spontaneous urticaria.Clin Exp Dermatol. 2025 Jan 27;50(2):357-364. doi: 10.1093/ced/llae319. Clin Exp Dermatol. 2025. PMID: 39107251
-
The CD63 basophil activation test as a diagnostic tool for assessing autoimmunity in patients with chronic spontaneous urticaria.Eur J Dermatol. 2019 Dec 1;29(6):614-618. doi: 10.1684/ejd.2019.3680. Eur J Dermatol. 2019. PMID: 31903951
-
Biomarkers of Autoimmune Chronic Spontaneous Urticaria.Curr Allergy Asthma Rep. 2023 Dec;23(12):655-664. doi: 10.1007/s11882-023-01117-7. Epub 2023 Dec 8. Curr Allergy Asthma Rep. 2023. PMID: 38064133 Review.
-
Lower IgA Levels in Chronic Spontaneous Urticaria Are Associated With Lower IgE Levels and Autoimmunity.Front Immunol. 2021 May 3;12:657211. doi: 10.3389/fimmu.2021.657211. eCollection 2021. Front Immunol. 2021. PMID: 34012441 Free PMC article.
-
Autoimmune chronic spontaneous urticaria.J Allergy Clin Immunol. 2022 Jun;149(6):1819-1831. doi: 10.1016/j.jaci.2022.04.010. J Allergy Clin Immunol. 2022. PMID: 35667749 Review.
Cited by
-
Relation of STAT3 rs1053005 Variation and miR-452-3p with Osteoarthritis Susceptibility and Severity and the Clinical Response to High-Molecular-Weight Hyaluronic Acid Injection in Osteoarthritis Patients.Diagnostics (Basel). 2023 Nov 27;13(23):3544. doi: 10.3390/diagnostics13233544. Diagnostics (Basel). 2023. PMID: 38066785 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous